Zoledronic acid in breast cancer: latest findings and interpretations - Wikidata - awgldk - TriplyDB

Zoledronic acid in breast cancer: latest findings and interpretations

Zoledronic acid in breast cancer: latest findings and interpretations

http://www.wikidata.org/entity/Q35534524

about

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?The pre-metastatic niche: is metastasis random?Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid.The anti-tumour effects of zoledronic acid Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion Role of interleukin-6 in cancer progression and therapeutic resistance.Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment.

P2860

Q33739204-6A74E7F5-AE4A-4BE3-9803-644D092916AB Q34524201-37D50206-24B7-4CD9-8B4B-2315AE4806B4 Q35667196-801609D8-3929-407D-ADF8-5E0807F48D1D Q35740351-217CC764-9802-4407-96E6-27E1F9299D05 Q36009806-D7DD65AB-D74B-43EA-98F6-0DFE54E38540 Q36491653-D71614B8-A036-4FE3-B520-6BD48B1551D3 Q37299295-AADCD782-56A8-4560-AF33-FE10356DD59C Q38853625-88BF08A5-C6F5-4688-8E91-72BCA7E426AD Q54240388-D59CA9E9-B369-4AE7-8C1F-2EF323D716AC

P2860

Zoledronic acid in breast cancer: latest findings and interpretations

http://www.wikidata.org/entity/Q35534524

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Zoledronic acid in breast cancer: latest findings and interpretations

@ast

Zoledronic acid in breast cancer: latest findings and interpretations

@en

type

label

Zoledronic acid in breast cancer: latest findings and interpretations

@ast

Zoledronic acid in breast cancer: latest findings and interpretations

@en

prefLabel

Zoledronic acid in breast cancer: latest findings and interpretations

@ast

Zoledronic acid in breast cancer: latest findings and interpretations

@en

P1433

Q35534524-BA1AACBA-DBF4-4A1D-BD23-BF57700CA222

P1476

Q35534524-818CF0CC-85FA-47FF-8ADD-76C28D748E2F

P2093

Q35534524-93F6956A-4686-423C-9081-25E04733C2BC

P2860

Q35534524-0A87E055-65F1-4B6C-AA2F-8CB81551C18B

Q35534524-15BD3DDD-06FC-45BF-BA2E-6DD89BC6D1F4

Q35534524-1B7B085B-7790-419A-9463-4B33FA119016

Q35534524-2A585751-4CD8-4B07-AFBB-6CA69DE6BA2C

Q35534524-2D32F741-F481-4369-B119-2A8F00E177E8

Q35534524-2DB5220E-7171-49F6-8693-D8A2063888E5

Q35534524-323C2F23-16BA-4A0E-8512-BBCB17E1C4AD

Q35534524-34BC2BA8-5E59-4DF6-8F63-C2F04D44B6A6

Q35534524-35DE2FB2-5D4C-48E7-90CB-18216A3B3ABD

Q35534524-35F51BF7-581A-4A80-87A7-D4DFD2695EBB

P304

Q35534524-0CC11111-6F9E-4D02-AAB5-80B3B8D77457

P31

Q35534524-CD5C8D02-6962-470F-898A-DE29107C06AA

P356

Q35534524-2C496866-80D7-40D4-AFC6-248E89F5FE3E

P433

Q35534524-C071F506-11F9-4477-B7CE-FE9644DD2C04

P478

Q35534524-714A1065-0A2A-486B-A679-26139E7F9EF4

P50

Q35534524-DC3F6BEF-DCCE-48CE-B97A-5B2B3837F7AE

P577

Q35534524-A58838B3-C95D-4C42-9E76-031311FA4D56

P5875

Q35534524-999A1D35-2283-4639-A247-838AB23C961C

P698

Q35534524-51B1500A-B0BB-44AE-999A-42B85977F13C

P932

Q35534524-A262D48F-DC40-4867-890D-DFEB7E90CC18

P356

1758834011420599

P1433

Therapeutic advances in medical oncology

P1476

Zoledronic acid in breast cancer: latest findings and interpretations

@en

P2093

Michael Gnant

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Tumor self-seeding by circulating cancer cells

Metastasis to bone: causes, consequences and therapeutic opportunities

Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.

Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.

Failure of goserelin ovarian ablation in premenopausal women with breast cancer: two case reports.

Bone turnover across the menopause transition : The role of gonadal inhibins.

The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.

Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole.

P304

293-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834011420599

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51799455

http://www.w3.org/2001/XMLSchema#string

P698

22084643

http://www.w3.org/2001/XMLSchema#string

P932

3210470

http://www.w3.org/2001/XMLSchema#string